KROS
Price
$9.98
Change
-$0.30 (-2.92%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
405.01M
27 days until earnings call
RAPT
Price
$1.06
Change
-$0.04 (-3.60%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
147.19M
34 days until earnings call
Ad is loading...

KROS vs RAPT

Header iconKROS vs RAPT Comparison
Open Charts KROS vs RAPTBanner chart's image
Keros Therapeutics
Price$9.98
Change-$0.30 (-2.92%)
Volume$49.89K
Capitalization405.01M
RAPT Therapeutics
Price$1.06
Change-$0.04 (-3.60%)
Volume$3.12K
Capitalization147.19M
KROS vs RAPT Comparison Chart
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. RAPT commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and RAPT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (KROS: $10.28 vs. RAPT: $1.11)
Brand notoriety: KROS and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 132% vs. RAPT: 131%
Market capitalization -- KROS: $405.01M vs. RAPT: $147.19M
KROS [@Biotechnology] is valued at $405.01M. RAPT’s [@Biotechnology] market capitalization is $147.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • KROS’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, KROS is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 4 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • KROS’s TA Score: 4 bullish, 6 bearish.
  • RAPT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both KROS and RAPT are a bad buy in the short-term.

Price Growth

KROS (@Biotechnology) experienced а -6.46% price change this week, while RAPT (@Biotechnology) price change was -21.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

KROS is expected to report earnings on May 01, 2025.

RAPT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($405M) has a higher market cap than RAPT($147M). RAPT YTD gains are higher at: -29.747 vs. KROS (-35.060). RAPT has higher annual earnings (EBITDA): -134.9M vs. KROS (-185.82M). KROS has more cash in the bank: 560M vs. RAPT (231M). RAPT has less debt than KROS: RAPT (4.49M) vs KROS (18.9M). KROS has higher revenues than RAPT: KROS (3.55M) vs RAPT (0).
KROSRAPTKROS / RAPT
Capitalization405M147M276%
EBITDA-185.82M-134.9M138%
Gain YTD-35.060-29.747118%
P/E RatioN/AN/A-
Revenue3.55M0-
Total Cash560M231M242%
Total Debt18.9M4.49M421%
TECHNICAL ANALYSIS
Technical Analysis
KROSRAPT
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKJAX9.82N/A
N/A
Allspring Premier Large Co Gr A
PARWX51.74N/A
N/A
Parnassus Value Equity Investor
GSVSX15.75N/A
N/A
Goldman Sachs Large Cap Value Svc
ICWIX6.03N/A
N/A
Integrity Mid-North American Resources I
EEMPX8.16N/A
N/A
MFS Emerging Markets Equity Research A

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-4.31%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
-3.35%
SNDX - RAPT
45%
Loosely correlated
-3.93%
SLGL - RAPT
45%
Loosely correlated
+3.31%
TRAW - RAPT
44%
Loosely correlated
-6.03%
More